Dr. Ramakrishna Awarded Healthcare Leadership Fellowship

You are here

Dr. Rohan Ramakrishna of Weill Cornell Medicine
04-26-2017

Dr. Rohan Ramakrishna, the Alvina and Willis Murphy Assistant Professor of Neurological Surgery, has been awarded a Healthcare Leadership Fellowship by Weill Cornell Medicine and the Weill Cornell Physician Organization. He is one of seven young physicians selected for the program, which fosters professional development and leadership.

“Dr. Ramakrishna is an outstanding neurosurgeon who is already a leader in the field of brain tumors, especially glioblastoma multiforme,” says Dr. Philip E. Stieg, professor and chair of the Weill Cornell Medicine Brain and Spine Center and Neurosurgeon-in-Chief of NewYork-Presbyterian/Weill Cornell Medical Center. “This fellowship recognizes his great potential, and will help cultivate his talent for leadership in healthcare delivery and policy.”

The fellowship, now in its sixth year, was established by Dr. Michael J. Wolk, chief contracting officer of the Weill Cornell Physician Organization, professor of clinical medicine, and president of the Michael J. Wolk Heart Foundation. Its goal is to prepare the next generation of physician leaders for the challenges of healthcare delivery and management in today's rapidly evolving environment.

Fellows are matched with mentor and attend policy and leadership courses organized by such major institutions as the Harvard School of Public Health, Intermountain Health Care, and the Institute for Healthcare Improvement.

Dr. Caitlin Hoffman, also of the Department of Neurological Surgery, was one of last year’s Healthcare Leadership Fellows. Through the mentoring and support she received, Dr. Hoffman initiated a tele-epilepsy network that will launch later this spring, and created an epilepsy research data repository to coincide with the launch of a new epilepsy monitoring unit (EMU) at NewYork-Presbyterian and Weill Cornell Medicine.

Dr. Ramakrishna, who was recently named Weill Cornell Medicine neurosurgical lead on the new William Rhodes and Louise Tilzer-Rhodes Center for Glioblastoma, and who directs the new Brain Metastases Program, will develop a project related to brain tumors.